Home Drug Study Omeprazole ( Prilosec) Drug study

Omeprazole ( Prilosec) Drug study

omeprazole-drug-study

Generic Name: Omeprazole
Brand Name:Losec,Prilosec
Classifications:gastrointestinal agent; proton pump inhibitor
Pregnancy Category:C
Availability: 10 mg, 20 mg, 40 mg capsules

Actions  
An antisecretory compound that is a gastric acid pump inhibitor. Suppresses gastric acid secretion by inhibiting the H+, K+-ATPase enzyme system [the acid (proton H+) pump] in the parietal cells.

Therapeutic effects  
Suppresses gastric acid secretion relieving gastrointestinal distress and promoting ulcer healing.

Uses   
Duodenal and gastric ulcer. Gastroesophageal reflux disease including severe erosive esophagitis (4 to 8 wk treatment). Long-term treatment of pathologic hypersecretory conditions such as Zollinger-Ellison syndrome, multiple endocrine adenomas, and systemic mastocytosis. In combination with clarithromycin to treat duodenal ulcers associated with Helicobacter pylori.

Contraindications 
Long-term use for gastroesophageal reflux disease, duodenal ulcers; lactation.

Route & dosage

Gastroesophageal Reflux, Erosive Esophagitis, Duodenal Ulcer
adult: PO  20 mg once/d for 4–8 wk

Gastric Ulcer
adult: PO  20 mg b.i.d. for 4–8 wk

Hypersecretory Disease
adult:PO  60 mg once/d up to 120 mg t.i.d.

Duodenal Ulcer Associated with H. pylori
adult:PO  40 mg once/d for 14 d, then 20 mg/d for 14 d, in combination with clarithromycin 500 mg t.i.d. for 14 d

Administration

Oral   
Give before food, preferably breakfast; capsules must be swallowed whole (do not open, chew, or crush).
Note: Antacids may be administered with omeprazole.

Adverse effects
CNS:Headache, dizziness, fatigue.
GI:Diarrhea, abdominal pain, nausea, mild transient increases in liver function tests.
Urogenital:Hematuria, proteinuria.
Skin:Rash.

Nursing implications 

Assessment & Drug Effects      

  • Lab tests: Monitor urinalysis for hematuria and proteinuria. Periodic liver function tests with prolonged use.

Patient & Family Education     

  • Report any changes in urinary elimination such as pain or discomfort associated with urination, or blood in urine.
  • Report severe diarrhea; drug may need to be discontinued.
  • Do not breast feed while taking this drug.
RNspeak
This community comprises professional nurses who possess exceptional literary skills. They come together to share their expertise in theoretical and clinical knowledge, nursing tips, facts, statistics, healthcare information, news, disease data, care plans, drugs, and all aspects encompassed by the field of nursing. The information presented here is provided by individual authors and is expressed with courtesy. It is important to note that the views expressed on various topics may not necessarily represent those of the entire community. The articles submitted to this platform are original, meticulously checked for minor typographical errors, and formatted to ensure compatibility with the site. The site's primary goal is to consistently enhance and disseminate healthcare information that is pertinent to the ever-evolving world we live in today.

1 COMMENT

LEAVE A REPLY

Please enter your comment!
Please enter your name here